# Replimune Group, Inc.: Form 8-K, filed May 20, 2021

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2021-05-20
- Accepted by EDGAR: May 20, 2021, 08:06 ET
- Period: 2021-05-20
- Accession: 0001104659-21-069613
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465921069613/tm2116920d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465921069613/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465921069613/tm2116920d1_8k.htm

Filed May 20, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-069613. Last ingested by Listed: Nov 11, 2026, 01:43 ET. No prices; not investment advice.